Back to Search Start Over

Impact of age on the outcomes of Takotsubo syndrome.

Authors :
Simon Frances B
Sans-Roselló J
Brugaletta S
Cerrato E
Alfonso F
Gonzalo N
Amat-Santos IJ
Fernández-Peregrina E
Teira Calderón A
Varghese JJ
Garg M
García-García HM
Source :
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Apr; Vol. 61, pp. 44-51. Date of Electronic Publication: 2023 Nov 03.
Publication Year :
2024

Abstract

Background: The impact on age on the short-term and long-term prognosis in patients with Takotsubo syndrome (TTS) is unclear. We aimed to evaluate whether age has prognostic implications during hospital stay and long-term follow-up of TTS patients.<br />Methods: 688 consecutive patients were admitted for TTS in 7 tertiary centers from January-2008 to June-2021. We divided our cohort into two groups (patients <75 years and ≥75 years). Clinical, analytical, and hemodynamic variables as well as in-hospital management were registered and compared between groups. Mortality rates during hospital stay and follow-up were assessed. Adverse cardiovascular events (ACE) were defined as the composite of cardiovascular death, heart failure event, acute myocardial infarction, stroke and symptomatic arrhythmia.<br />Results: Median age was 74.7 years and 49.4 % were ≥75 years. 86.9 % were women and 22.3 % were secondary forms of TTS. In-hospital mortality was 3.6 % (1.5 % cardiovascular). Median clinical follow-up was 4.3 years. Mortality during the follow-up period was 23 % (5.0 % cardiovascular) while ACE were 22.5 %, mainly due to heart failure events. Kaplan-Meier curves showed both higher rates of mortality and ACE in ≥75 years group (30.2 % vs 15.8 %; p < 0.001 and 28.3 % vs 16.7 %; p < 0.001). Age was independently associated with higher rates of overall mortality and ACE in patients with TTS. Hypertension, absence of sinus rhythm, Killip class > I and a more impaired coronary microvascular resistance were also associated to ACE in TTS patients.<br />Conclusions: Advanced age was associated with higher rate of overall mortality and ACE during long-term follow-up in TTS patients.<br />Competing Interests: Declaration of competing interest Dr. Hector M. Garcia-Garcia reports the following institutional grant support: Biotronik, Boston Scientific, Medtronic, Abbott, Neovasc, Shockwave, Phillips and Corflow. The following is the supplementary data related to this article. Supplementary data to this article can be found online at https://doi.org/10.1016/j.carrev.2023.10.018.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-0938
Volume :
61
Database :
MEDLINE
Journal :
Cardiovascular revascularization medicine : including molecular interventions
Publication Type :
Academic Journal
Accession number :
37949720
Full Text :
https://doi.org/10.1016/j.carrev.2023.10.018